Efficacy and safety of alirocumab in statin-intolerant patients over 3 years: open-label treatment period of the ODYSSEY ALTERNATIVE trial
Titel:
Efficacy and safety of alirocumab in statin-intolerant patients over 3 years: open-label treatment period of the ODYSSEY ALTERNATIVE trial
Auteur:
Moriarty, Patrick M. Thompson, Paul D. Cannon, Christopher P. Guyton, John R. Bergeron, Jean Zieve, Franklin J. Bruckert, Eric Jacobson, Terry A. Baccara-Dinet, Marie T. Zhao, Jian Donahue, Stephen Ali, Shazia Manvelian, Garen Pordy, Robert